Twitter | Search | |
Search Refresh
Marieke Coenen Oct 22
The yearly symposium of the Netherlands Network Precision Medicine () is approaching! The theme of this year is “Functional work in precision medicine: from suspicion to confirmation”. Hope to see you all on Thursday 28th of November 2019.
Reply Retweet Like
Laura Ramsey Oct 29
So excited that we finally have discrete data in the EMR! I know you are happy for me. Now to work on making the alerts more informative. I hope that doesn't take 4 years too.
Reply Retweet Like
Alexandra Fritzen Jun 14
Repping and at with . Remember: Your data is a graph!
Reply Retweet Like
Roseann Gammal Aug 5
"Instead of rejecting PGx because it is imperfect, we need to recognize its limitations but also open our minds to the incredible possibilities it may offer if we push forward together." Excellent editorial by about testing:
Reply Retweet Like
Keito Hoshitsuki, PharmD Sep 20
There is definite benefit to validating a pt’s prior med experience with . But also, if we embrace a preemptive model, we can PREVENT adverse outcomes and not just a “oh that’s why” result.
Reply Retweet Like
Chad Bousman Apr 4
Replying to @BousmanChad
To be clear. I'm not defending Inova, the MediMap tests, or their marketing practices. I am defending the evidence base. There are several gene-drug pairs on the MediMap test that lack solid evidence but CYP2C19-escitalopram is not one of them!
Reply Retweet Like
Ellie McDonagh Aug 8
Proud to have been part of implementing DPYD results into our genome interpretation pipeline for reporting back to clinicians; hopefully this will help avoid severe toxicity in cancer patients
Reply Retweet Like
Laura Ramsey Feb 8
Yes! is among those implementing , thanks for including us!
Reply Retweet Like
Lisa Brown, PhD Jun 3
Reply Retweet Like
Pharmacopsychiatry Mar 24
Excellent publication addressing the question if commercial tests support evidence-based genetic testing based on expert consensus guidelines such as . This is the 1st accepted publication from the upcoming Special Issue on in psychiatry. Stay tuned!
Reply Retweet Like
PGX Comics May 9
Do you know PGX has it's own pressing facility? You can raise the value of your books by getting them pressed & cleaned by .
Reply Retweet Like
vicky pratt Oct 10
Thank you for inviting me to speak on guidelines
Reply Retweet Like
Minoli Perera Jul 29
the newest issue of in on . Check out our review on African Americans! The Advantages and Challenges of Diversity in Pharmacogenomics: Can Minority Populations Bring Us Closer to Implementation? -
Reply Retweet Like
Christopher Ridgeway 3h
Looking to get in early on individualized medicine? Stone Clinical is at the leading edge of pharmacogenetics () testing. Discover how you can enhance your clinical effectiveness by removing trial and error from the treatment process.
Reply Retweet Like
Chris Gignoux Sep 11
Replying to @popgenepi
KC: describing framework she and SING collaborators published here: , application in study of nicotine metabolism
Reply Retweet Like
philempey Sep 18
Proposed MolDX Local Coverage Determination (Palmetto GBA) for testing! Includes panels, actionable use defined by FDA OR level A/B, and has indications for CYP2D6, CYP2C19, CYP2C9, HLA-B*15.02 and HLA-A31.01 See
Reply Retweet Like
Rob Wright Sep 3
What training is involved to insure pharmacists are able to appropriately interpret test results and apply them to individual patients? How is this information being integrated into the patient’s health record for other healthcare professionals to use?
Reply Retweet Like
Pharmacogenomics Access & Reimbursement Coalition Jun 6
Thrilled to discuss some of the issues surrounding reimbursement of testing in a health-system setting today at the conference.
Reply Retweet Like
PittPGx Oct 3
Great work (w/ and ). It's best to learn using real data!
Reply Retweet Like
Nick Boulanger Jul 19
Reply Retweet Like